Clinical trial
Determination of Carboplatin's Optimal Plasmatic Exposure
NCT00145028 · Institut Claudius Regaud, Other · Completed
Key facts
| NCT number | NCT00145028 |
|---|---|
| Title | Determination of Carboplatin's Optimal Plasmatic Exposure |
| Official title | Determination of Carboplatin's Optimal Plasmatic Exposure |
| Lead sponsor | Institut Claudius Regaud, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Neoplasms |
| Intervention type | Drug |
| Interventions | Carboplatin |
| Enrollment | 400 |
| Start date | May 1, 2005 |
| Primary completion | Dec 1, 2007 |
| Completion | Feb 1, 2009 |
| First posted | Sep 5, 2005 |
| Last update posted | Mar 18, 2009 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: